HomeT06 • FRA
add
Visen Pharmaceuticals
Previous close
€5.05
Day range
€5.10 - €5.10
Year range
€4.53 - €7.93
Market cap
5.43B HKD
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | -48.00K | -100.04% |
Operating expense | 53.66M | 51.22% |
Net income | -52.75M | -27.94% |
Net profit margin | 109.89K | 289,511.59% |
Earnings per share | — | — |
EBITDA | -53.62M | -173.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 203.59M | -41.46% |
Total assets | 293.82M | -33.79% |
Total liabilities | 52.55M | -0.70% |
Total equity | 241.28M | — |
Shares outstanding | 9.34M | — |
Price to book | 0.20 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -52.75M | -27.94% |
Cash from operations | -38.45M | 66.73% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -663.00K | 68.96% |
Net change in cash | -39.06M | 66.83% |
Free cash flow | — | — |
About
Founded
2018
Website
Employees
58
